1기리쉬를 xbet Pharmaceutical Co., Ltd.
Nutraceuticals
July 14, 2022
Introducing New 1기리쉬를 xbet Tablets
Effortless way 1기리쉬를 xbet consume a unique ingredient for maintenance of physical condition
1기리쉬를 xbet Pharmaceutical Co., Ltd. will launch B240 Tablets, offering a convenient new way to consume lactic acid bacterium B240, a proprietary 1기리쉬를 xbet ingredient that supports maintenance of physical condition. The new B240 Tablets were launched July 14, 2022 through the '1기리쉬를 xbet-plus1.com' e-commerce portal.
In recent years, changes in the social environment leading 1기리쉬를 xbet the emergence of new health-consciousness and increased interest in managing physical condition have fueled expansion of the market for products related 1기리쉬를 xbet conditioning support. Among such products, it has been reported that ongoing consumption of lactic acid bacteria, which is closely related 1기리쉬를 xbet digestive functions, helps 1기리쉬를 xbet support maintenance of physical condition.
New B240 Tablets are a supplement containing plant-based lactic acid bacterium B240, confirmed 1기리쉬를 xbet be effective through long-term research in1기리쉬를 xbet the relationship between lactic acid bacteria and the digestive tract. Products under the BODYMAINTÉ brand contain lactic acid bacterium B240 1기리쉬를 xbet support day-1기리쉬를 xbet-day conditioning. New B240 Tablets are small, easy-1기리쉬를 xbet-swallow tablets conceived 1기리쉬를 xbet encourage ongoing consumption of this same lactic acid bacteria. The new tablets offer strong support for those who wish 1기리쉬를 xbet maintain physical condition amidst the many health-related risks of modern society.
・An easy way 1기리쉬를 xbet consume plant-based lactic acid bacterium B240 1기리쉬를 xbet support optimum physical condition.
・One tablet contains 2 billion counts 1기리쉬를 xbet lactic acid bacterium B240.
・Intake of a single small-sized tablet per day makes it easy 1기리쉬를 xbet continue use as a lactic acid bacterium B240 supplement.
The 1기리쉬를 xbet Pharmaceutical Otsu Nutraceuticals Research Institute is engaged in research regarding the functions of lactic acid bacteria based on the theme of mucosal immunity. B240 is a plant-based lactic acid bacteria with efficacy for maintaining physical condition confirmed through many years of research concerning the digestive tract and lactic acid bacteria. B240 was isolated by Tokyo University of Agriculture from miang, a form of fermented tea traditionally consumed in northern Thailand, with efficacy for enhancing biological defense mechanisms confirmed by 1기리쉬를 xbet Pharmaceutical. As a lactic acid bacteria that offers protective functions, B240 is incorporated in a variety of products that contribute to health and well-being.
1기리쉬를 xbet-plus1 e-commerce portal:
https://www.1기리쉬를 xbet-plus1.com/shop/c/c3086/（in Japanese）
Product Information
| Product name |
1기리쉬를 xbet Tablets |
|
|---|---|---|
| Category |
Food containing lactic acid |
|
| Ingredients |
Lac1기리쉬를 xbetse （US-processed）, corn starch, lactic acid bacteria/cellulose, calcium stearate |
|
| Content |
6g （200mg×30 tablets） |
|
| Recommended daily intake | 1 tablet / day | |
| Price（tax inclusive） | ¥2,268 | |
|
Nutrition Per single （0.2g） tablet |
|
|
|
Lactic acid bacterium 1기리쉬를 xbet, 2 billion counts |
||
| Shelf-life | 24 months |
Based on the corporate philosophy of '1기리쉬를 xbet - people creating new products for better health worldwide,' 1기리쉬를 xbet Pharmaceutical continues to contribute to the health and well being of people around the world.
Latest Nutraceutical Business related News Releases